×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

GERD and NERD Treatment Market Share

ID: MRFR/Pharma/4106-CR
90 Pages
Rahul Gotadki
February 2018

Americas Gerd and Nerd Treatment Market Research Report Information, By Drug Class (Antacids (Acid Neutralizers), Proton Pump Inhibitors, H2 Receptor Blocker), Dosage Form (Solid And Liquid), End User (Hospitals and Clinics, Research Centers, And Others) -Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

GERD and NERD Treatment Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Share

GERD and NERD Treatment Market Share Analysis

Introduce gastroesophageal reflux ailment (GERD) and non-erosive reflux disease (NERD) as commonplace gastrointestinal situations characterized by the reflux of belly acid into the esophagus, causing signs and symptoms including heartburn, regurgitation, and chest ache. Analyze the GERD and NERD Treatment remedy market, together with prevalence fees, patient demographics, and treatment options. Segment the market primarily based on elements including ailment severity, patient signs, remedy possibilities, and healthcare settings. Evaluate competition imparting prescribed drugs, way of life adjustments, and surgical interventions for GERD and NERD Treatment remedies. Assess their market presence, product portfolios, pricing techniques, and patient satisfaction stages. Develop unique selling propositions (USPs) for products or services targeting GERD and NERD Treatment treatment. Emphasize elements that include treatment efficacy, safety profile, symptom relief, affected person compliance, and comfort of management. Develop and promote pharmaceutical interventions for GERD and NERD Treatment remedies, which include proton pump inhibitors (PPIs), H2-receptor antagonists, and prokinetic marketers. Highlight the efficacy, safety profile, dosing flexibility, and adherence blessings of pharmacological remedies. Offer surgical and endoscopic interventions for GERD and NERD Treatment sufferers who are refractory to medical therapy or decide upon procedural interventions. Promote procedures inclusive of laparoscopic fundoplication, magnetic sphincter augmentation, and endoscopic radiofrequency ablation as effective remedy alternatives. Collaborate with payers, healthcare structures, and regulatory groups to steady favorable coverage and repayment rules for GERD and NERD Treatment treatments. Explore opportunities for market growth in emerging markets and regions with growing healthcare infrastructure. Customize product offerings, distribution channels, and advertising strategies to satisfy the precise needs and regulatory necessities of target markets. Form strategic partnerships with instructional institutions, research companies, and patient advocacy agencies to advance studies, innovation, and attention in the discipline of GERD and NERD Treatment remedies. Collaborate on scientific trials, outcomes research, and public fitness initiatives to enhance treatment consequences and patients' enjoyment of existence. Implement exceptional guarantee packages and performance metrics to reveal and enhance the excellence of GERD and NERD Treatment treatments. Emphasize the affected person's protection, remedy results, and affected person's pleasure to pressure non-stop improvement efforts. Ensure all advertising and promotional activities observe ethical standards and regulatory suggestions governing the healthcare enterprise.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

At what CAGR is the Americas GERD & NERD treatment market projected to grow during the forecast period?

Americas GERD & NERD treatment market is projected to grow at a 7.63% CAGR By 2032

Which region is expected to dominate the GERD & NERD treatment market?

The Americas is expected to dominate the GERD & NERD treatment market.

What are the key factors driving the Americas GERD & NERD treatment market?

Rising incidence of reflux disorder and increasing cases of smoking are key factors driving the GERD & NERD treatment market.

Which drug class segment will dominate the Americas GERD & NERD treatment market?

Proton pump inhibitors will dominate the GERD & NERD treatment market.

What are the end users of the Americas GERD & NERD treatment market?

End users of the GERD & NERD treatment market include research centers, hospitals and clinics, and others.

Market Summary

The Global Americas GERD and NERD Treatment Market is projected to grow significantly from 2.16 USD Billion in 2024 to 5.22 USD Billion by 2035.

Key Market Trends & Highlights

Americas GERD & NERD Treatment Key Trends and Highlights

  • The market is expected to experience a compound annual growth rate (CAGR) of 8.36% from 2025 to 2035.
  • By 2035, the market valuation is anticipated to reach 5.22 USD Billion, indicating robust growth potential.
  • In 2024, the market is valued at 2.16 USD Billion, reflecting the current demand for GERD and NERD treatments.
  • Growing adoption of innovative treatment options due to increasing prevalence of GERD and NERD is a major market driver.

Market Size & Forecast

2024 Market Size 2.16 (USD Billion)
2035 Market Size 5.22 (USD Billion)
CAGR (2025-2035) 8.36%
Largest Regional Market Share in 2024 latin_america)

Major Players

AstraZeneca Plc (U.K), Boston Scientific Corporation (U.S.), Cempra Inc. (U.S.), Eisai Co., Ltd. (Japan), EndoGastric Solutions Inc. (U.S.), EndoStim Inc. (U.S.), GlaxoSmithKline Plc (U.K), Ironwood Pharmaceuticals, Inc. (U.S.), Jeil pharmaceutical Co.Ltd. (South Korea), Johnson & Johnson (U.S.), Mederi Therapeutics Inc. (U.S.), Medigus Ltd. (Israel), Medtronic Inc. (U.S.), Merck & CO., Inc. (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Teva Pharmaceuticals Industries Limited (Israel), Torax Medical (U.S.), Valeant Pharmaceuticals International, Inc. (Canada), Carbon Medical technologies (U.S.), Allegiant health (U.S.), Tya pharmaceuticals (U.S.), Sanofi (France)

Market Trends

GERD and NERD Treatment Market Market Drivers

Aging Population

The aging population in the Americas serves as a significant driver for the Global Americas GERD and NERD Treatment Market Industry. As individuals age, the prevalence of GERD and NERD tends to increase due to physiological changes and comorbidities associated with older age. This demographic shift necessitates a greater focus on treatment options tailored to the needs of older adults. With the population aged 65 and older projected to reach 80 million by 2040, the demand for effective GERD and NERD treatments is expected to rise correspondingly, thereby propelling market growth.

Market Growth Projections

The Global Americas GERD and NERD Treatment Market Industry is projected to experience substantial growth over the next decade. With an estimated market value of 2.16 USD Billion in 2024, it is expected to expand to 5.22 USD Billion by 2035, reflecting a CAGR of 8.36% from 2025 to 2035. This growth trajectory indicates a robust response to the increasing prevalence of GERD and NERD, advancements in treatment options, and heightened awareness among patients and healthcare providers. The market dynamics suggest a promising future for stakeholders involved in the development and distribution of GERD and NERD treatments.

Increased Awareness and Diagnosis

Growing awareness regarding GERD and NERD symptoms among the general population and healthcare providers is a crucial driver for the Global Americas GERD and NERD Treatment Market Industry. Enhanced educational initiatives and campaigns have led to improved diagnosis rates, allowing for timely intervention. As more individuals seek medical advice for reflux-related symptoms, the demand for diagnostic tools and treatment options is likely to rise. This trend is reflected in the projected compound annual growth rate (CAGR) of 8.36% from 2025 to 2035, indicating a robust market response to increased awareness and proactive healthcare measures.

Rising Prevalence of GERD and NERD

The increasing prevalence of gastroesophageal reflux disease (GERD) and non-erosive reflux disease (NERD) is a primary driver for the Global Americas GERD and NERD Treatment Market Industry. Recent estimates indicate that approximately 20% of the American population experiences GERD symptoms, contributing to a growing demand for effective treatment options. This trend is expected to continue, with the market projected to reach 2.16 USD Billion in 2024. The rising incidence of obesity and lifestyle factors, such as diet and stress, further exacerbate the condition, leading to a heightened focus on therapeutic interventions.

Advancements in Treatment Modalities

Innovations in treatment modalities significantly influence the Global Americas GERD and NERD Treatment Market Industry. The introduction of novel pharmacological agents, including proton pump inhibitors and H2 receptor antagonists, has transformed the management of GERD and NERD. Additionally, minimally invasive surgical techniques, such as fundoplication, have gained traction, offering patients effective alternatives to traditional surgery. As these advancements continue to evolve, they are likely to enhance patient outcomes and satisfaction, driving market growth. The anticipated expansion of the market to 5.22 USD Billion by 2035 underscores the importance of ongoing research and development in this field.

Lifestyle Changes and Dietary Habits

Shifts in lifestyle and dietary habits contribute to the rising incidence of GERD and NERD, thus impacting the Global Americas GERD and NERD Treatment Market Industry. The consumption of high-fat, spicy foods, and the prevalence of sedentary lifestyles have been linked to increased reflux symptoms. As awareness of these correlations grows, there is a potential for increased demand for therapeutic interventions. This trend may be further amplified by public health initiatives aimed at promoting healthier lifestyles, which could lead to a more proactive approach to managing GERD and NERD.

Market Segment Insights

Regional Insights

Key Companies in the GERD and NERD Treatment Market market include

Industry Developments

Future Outlook

GERD and NERD Treatment Market Future Outlook

The Americas GERD & NERD Treatment Market is projected to grow at an 8.36% CAGR from 2024 to 2035, driven by increasing prevalence and advancements in treatment options.

New opportunities lie in:

  • Develop innovative drug delivery systems to enhance patient compliance and treatment efficacy.
  • Invest in telehealth solutions for remote monitoring and management of GERD & NERD patients.
  • Explore partnerships with technology firms to integrate AI in diagnostic processes.

By 2035, the market is expected to demonstrate robust growth, reflecting evolving treatment paradigms and patient needs.

Market Segmentation

Report Scope

FAQs

At what CAGR is the Americas GERD & NERD treatment market projected to grow during the forecast period?

Americas GERD & NERD treatment market is projected to grow at a 7.63% CAGR By 2032

Which region is expected to dominate the GERD & NERD treatment market?

The Americas is expected to dominate the GERD & NERD treatment market.

What are the key factors driving the Americas GERD & NERD treatment market?

Rising incidence of reflux disorder and increasing cases of smoking are key factors driving the GERD & NERD treatment market.

Which drug class segment will dominate the Americas GERD & NERD treatment market?

Proton pump inhibitors will dominate the GERD & NERD treatment market.

What are the end users of the Americas GERD & NERD treatment market?

End users of the GERD & NERD treatment market include research centers, hospitals and clinics, and others.

  1. Report Prologue
  2. Market Introduction
    1. Definition 14
    2. Scope of the Study 14
      1. Research Objective 14
      2. Assumptions
      3. Limitations 14
  3. Research Methodology
    1. Research Methodology 17
    2. Research Methodology 20
  4. Primary
  5. Data Points Received from the Doctors/ Gastrologist:
  6. Data points received from the Manufacturer/ Pharmaceutical Companies:
  7. Data points received from Hospitals, Clinics: 18
  8. Secondary
  9. Market Share Analysis 22
  10. Trade Analysis
  11. Market Pricing Approach 22
  12. Market Dynamics
    1. Introduction
    2. Drivers 24
      1. Increasing cases of smoking to boost the market
      2. Rising cases of reflux disorder during
      3. Changing lifestyle and irregular
      4. Increasing incidence of acid
      5. Growing geriatric population (impact weightage-
      6. Increasing demands for endoscopy biopsy procedures for early
    3. growth (Impact weightage- 20%) 24
    4. pregnancy (impact weightage- 15%) 25
    5. dietary habits (Impact weightage- 15%) 26
    6. reflux disorder (heartburn) will boost the American GERD& NERD treatment market
    7. (Impact weightage- 25%) 27
    8. 15%) 28
    9. diagnosis (Impact weightage- 10%) 29
    10. Restraints 30
      1. Loss of patent
      2. High
    11. exclusivity and lack of pipeline drugs (impact weightage- 55%) 30
    12. cost of the gastroscopes (weightage impact- 45%) 31
    13. Opportunity 32
    14. Development of new drugs 32
    15. Mega Trends 32
    16. Macroeconomic Indicators
    17. Technology Trends & Assessment 33
  13. Market Factor
    1. Analysis
    2. Porters Five forces Model 34
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers 35
      3. Threat of New Entrants 35
      4. Threat of Substitutes 35
      5. Intensity of Rivalry 36
    3. Value
      1. R&D 37
      2. Manufacturing 37
      3. Distribution
      4. Post-Sales Monitoring 37
    4. Chain Analysis 36
    5. & Sales 37
    6. Demand & Supply:
    7. Gap Analysis 38
    8. Pricing Analysis 38
    9. Investment Opportunity Analysis
  14. Americas GERD & NERD Treatment Market, by Drug class
    1. Introduction 39
    2. Antacids (Acid Neutralizers) 40
    3. Proton Pump Inhibitors
      1. Esomeprazole 41
      2. Omeprazole 42
      3. Pantoprazole 42
      4. Lansoprazole 43
      5. Dexlansoprazole 43
      6. Rabeprazole 43
    4. H2 receptor blocker 44
      1. Ranitidine 44
      2. Famotidine 45
      3. Cimetidine 45
      4. Nizatidine 46
    5. Pro kinetic agents 46
      1. Domperidone 46
      2. Metoclopramide 47
      3. Itopride 47
      4. Cisapride 48
      5. Benzamide 48
      6. Mosapride
      7. Erythromycin 49
    6. Prucalopride 47
    7. Antidepressants 49
    8. Calcium Channel
    9. Blockers 50
  15. Americas GERD & NERD Treatment Market, by Dosage Form
    1. Introduction 51
    2. Solid 52
    3. Liquid 52
  16. Americas
  17. GERD & NERD Treatment Market, by End User
    1. Introduction 53
    2. Hospitals & Clinics 54
    3. Research Centers 54
  18. Americas GERD
  19. & NERD Treatment Market, by Region
    1. Introduction 55
    2. North America
      1. U.S. 60
      2. Canada 63
    3. South America 66
    4. Competitive Landscape
    5. Introduction 69
    6. Company Share Analysis
  20. Company Profiles
    1. AstraZeneca 70
      1. Company Overview
      2. Financials 70
      3. Products 70
      4. Strategy 70
      5. Key Developments 70
    2. Addex Pharmaceuticals 71
      1. Company
      2. Financials 71
      3. Products 71
      4. Strategy
      5. Key Developments 71
    3. Overview 71
    4. Takeda Pharmaceutical 72
      1. Financials 72
      2. Products 72
      3. Key Developments 72
    5. Company Overview 72
    6. Strategy 72
    7. Eisai Co., Ltd 73
      1. Financials 73
      2. Products 73
      3. Key Developments 73
    8. Company Overview 73
    9. Strategy 73
    10. Medigus Ltd 74
      1. Financials 74
      2. Products 74
      3. Key Developments 74
    11. Company Overview 74
    12. Strategy 74
    13. RaQualia Pharma Inc 75
      1. Company Overview 75
      2. Financials 75
      3. Products 75
      4. Strategy 75
      5. Key Developments 75
    14. Torax Medical 76
      1. Company Overview 76
      2. Financials 76
      3. Products 76
      4. Strategy 76
      5. Key Developments 76
    15. Carbon Medical technologies
      1. Company Overview 77
      2. Financials 77
      3. Products
      4. Strategy 77
      5. Key Developments 77
    16. Endogastric
      1. Company Overview 78
      2. Financials 78
      3. Strategy 78
      4. Key Developments 78
    17. Solutions 78
    18. Products 78
    19. Medtronic
      1. Company Overview 79
      2. Financials 79
      3. Products
      4. Strategy 79
      5. Key Developments 79
    20. Pfizer 80
      1. Company Overview 80
      2. Financials 80
      3. Products 80
      4. Strategy 80
      5. Key Developments 80
    21. Novartis AG. 81
      1. Company Overview 81
      2. Financials 81
      3. Products 81
      4. Strategy 81
      5. Key Developments 81
    22. GlaxoSmithKline
      1. Company Overview 82
      2. Financials 82
      3. Strategy 82
      4. Key Developments 82
      5. Company Overview 83
      6. Financials
      7. Products 83
      8. Strategy 83
      9. Key Developments
    23. plc 82
    24. Products 82
    25. Valeant Pharmaceuticals 83
    26. Ironwood Pharmaceuticals, Inc. 84
      1. Company Overview 84
      2. Financials 84
      3. Products 84
      4. Strategy 84
    27. Key Developments 84
  21. Appendix
    1. Discussion Blue Print 85
  22. MRFR Conclusion
    1. Key Findings 87
      1. From CEO’s View
      2. Unmet Needs 87
    2. Point 87
    3. Key companies to watch 87
  23. List of Tables
  24. PRIMARY INTERVIEWS 19
  25. AMERICAS GERD
  26. & NERD TREATMENT MARKET, BY ANTACIDS (ACID NEUTRALIZERS), 2023 & 2030 (USD
    1. MILLION) 40
  27. AMERICAS GERD & NERD TREATMENT MARKET, BY PROTON PUMP
    1. INHIBITORS, 2023 TO 2030 (USD MILLION) 41
  28. AMERICAS GERD & NERD
  29. TREATMENT MARKET, BY ESOMEPRAZOLE, 2023 TO 2030 (USD MILLION) 41
  30. AMERICAS
  31. GERD & NERD TREATMENT MARKET, BY OMEPRAZOLE, 2023 TO 2030 (USD MILLION) 42
  32. AMERICAS GERD & NERD TREATMENT MARKET, BY PANTOPRAZOLE, 2023 TO 2030
    1. (USD MILLION) 42
  33. AMERICAS GERD & NERD TREATMENT MARKET, BY LANSOPRAZOLE,
  34. AMERICAS GERD & NERD TREATMENT MARKET,
    1. BY DEXLANSOPRAZOLE, 2023 TO 2030 (USD MILLION) 43
  35. AMERICAS GERD &
  36. NERD TREATMENT MARKET, BY RABEPRAZOLE, 2023 TO 2030 (USD MILLION) 43
    1. TABLE
  37. AMERICAS GERD & NERD TREATMENT MARKET, BY H2 RECEPTOR BLOCKER, 2023 TO 2030
    1. (USD MILLION) 44
  38. AMERICAS GERD & NERD TREATMENT MARKET, BY RANITIDINE,
  39. AMERICAS GERD & NERD TREATMENT MARKET,
    1. BY FAMOTIDINE, 2023 TO 2030 (USD MILLION) 45
  40. AMERICAS GERD& NERD
  41. TREATMENT MARKET, BY CIMETIDINE, 2023 TO 2030 (USD MILLION) 45
  42. AMERICAS
  43. GERD & NERD TREATMENT MARKET, BY NIZATIDINE, 2023 TO 2030 (USD MILLION) 46
  44. AMERICAS GERD & NERD TREATMENT MARKET, BY DOMPERIDONE, 2023 TO 2030
    1. (USD MILLION) 46
  45. AMERICAS GERD & NERD TREATMENT MARKET, BY METOCLOPRAMIDE,
  46. AMERICAS GERD & NERD TREATMENT MARKET,
    1. BY ITOPRIDE, 2023 TO 2030 (USD MILLION) 47
  47. AMERICAS GERD & NERD
  48. TREATMENT MARKET, BY PRUCALOPRIDE, 2023 TO 2030 (USD MILLION) 47
  49. AMERICAS
  50. GERD & NERD TREATMENT MARKET, BY CISAPRIDE, 2023 TO 2030 (USD MILLION) 48
  51. AMERICAS GERD & NERD TREATMENT MARKET, BY BENZAMIDE, 2023 TO 2030
    1. (USD MILLION) 48
  52. AMERICAS GERD & NERD TREATMENT MARKET, BY MOSAPRIDE,
  53. AMERICAS GERD & NERD TREATMENT MARKET,
    1. BY ERYTHROMYCIN, 2023 TO 2030 (USD MILLION) 49
  54. AMERICAS GERD &
  55. NERD TREATMENT MARKET, BY ANTIDEPRESSANTS, 2023 TO 2030 (USD MILLION) 49
    1. TABLE
  56. AMERICAS GERD & NERD TREATMENT MARKET, BY CALCIUM CHANNEL BLOCKERS, 2023
    1. TO 2030 (USD MILLION) 50
  57. AMERICAS GERD & NERD TREATMENT MARKET,
    1. BY SOLID, 2023 TO 2030 (USD MILLION) 52
  58. AMERICAS GERD & NERD TREATMENT
  59. MARKET, BY LIQUID, 2023 TO 2030 (USD MILLION) 52
  60. AMERICAS GERD &
  61. NERD TREATMENT MARKET, BY HOSPITALS & CLINICS, 2023 TO 2030 (USD MILLION) 54
  62. AMERICAS GERD & NERD TREATMENT MARKET, BY RESEARCH CENTERS, 2023
    1. TO 2030 (USD MILLION) 54
  63. AMERICAS GERD & NERD TREATMENT MARKET,
    1. BY REGION, 2023 TO 2030 (USD MILLION) 56
  64. NORTH AMERICA GERD &
  65. NERD TREATMENT MARKET, BY DRUG CLASS, 2023-2030 (USD MILLION) 57
  66. NORTH
  67. AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 57
  68. NORTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD
    1. MILLION) 58
  69. NORTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE,
  70. NORTH AMERICA GERD & NERD TREATMENT
  71. MARKET, BY DOSAGE FORM, 2023-2030 (USD MILLION) 59
  72. NORTH AMERICA GERD
  73. & NERD TREATMENT MARKET, BY END USER, 2023-2030 (USD MILLION) 59
    1. TABLE
  74. U.S. GERD & NERD TREATMENT MARKET, BY DRUG CLASS, 2023-2030 (USD MILLION)
  75. U.S. GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD
    1. MILLION) 60
  76. U.S. GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030
    1. (USD MILLION) 61
  77. U.S. GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030
    1. (USD MILLION) 61
  78. U.S. GERD & NERD TREATMENT MARKET, BY DOSAGE
    1. FORM, 2023-2030 (USD MILLION) 62
  79. U.S. GERD & NERD TREATMENT MARKET,
    1. BY END USER, 2023-2030 (USD MILLION) 62
  80. CANADA GERD & NERD TREATMENT
  81. MARKET, BY DRUG CLASS, 2023-2030 (USD MILLION) 63
  82. CANADA GERD &
  83. NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 63
  84. CANADA
  85. GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 64
    1. TABLE
  86. CANADA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 64
  87. CANADA GERD & NERD TREATMENT MARKET, BY DOSAGE FORM, 2023-2030 (USD
    1. MILLION) 65
  88. CANADA GERD & NERD TREATMENT MARKET, BY END USER,
  89. SOUTH AMERICA GERD & NERD TREATMENT
  90. MARKET, BY DRUG CLASS, 2023-2030 (USD MILLION) 66
  91. SOUTH AMERICA GERD
  92. & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 66
  93. SOUTH
  94. AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 67
  95. SOUTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD
    1. MILLION) 67
  96. SOUTH AMERICA GERD & NERD TREATMENT MARKET, BY DOSAGE
    1. FORM, 2023-2030 (USD MILLION) 68
  97. SOUTH AMERICA GERD & NERD TREATMENT
  98. MARKET, BY END USER, 2023-2030 (USD MILLION) 68
  99. List of Figures
  100. AMERICAS GERD & NERD TREATMENT MARKET, BY DRUG CLASS, 2023 &
  101. AMERICAS GERD & NERD TREATMENT MARKET, BY
    1. DOSAGE FORM, 2023 & 2030 (USD MILLION) 12
  102. AMERICAS GERD &
  103. NERD TREATMENT MARKET, BY END USER, 2023 & 2030 (USD MILLION) 13
    1. FIGURE
  104. MARKET STRUCTURE 15
  105. RESEARCH METHODOLOGY 16
  106. DATA TRIANGULATION
    1. PRIMARY 19
  107. DATA TRIANGULATION METHOD 21
  108. PORTER’S
    1. FIVE FORCES MODEL 34
  109. AMERICAS GERD & NERD TREATMENT MARKET, BY
    1. DRUG CLASS, 2023 & 2030 (USD MILLION) 39
  110. AMERICAS GERD &
  111. NERD TREATMENT MARKET, BY DOSAGE FORM, 2023 & 2030 (USD MILLION) 51
    1. FIGURE
  112. AMERICAS GERD & NERD TREATMENT MARKET, BY END USER, 2023 & 2030 (USD
    1. MILLION) 53
  113. AMERICAS GERD & NERD TREATMENT MARKET, BY END USER,

Americas GERD & NERD Treatment Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓